The appearance of retinopathy and progression to proliferative retinopathy: the WHO multinational study of vascular disease in diabetes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2001-09

AUTHORS

H. Keen, E. T. Lee, D. Russell, E. Miki, P. H. Bennett, M. Lu, and the WHO Multinational Study Group

ABSTRACT

.Aims/hypothesis: We aimed to estimate incidences of any retinopathy and proliferative diabetic retinopathy (PDR) by direct ophthalmoscopy and relate them to baseline risk factors in re-examined diabetic survivors from 10 centres of the WHO Multinational Study of Vascular Disease in Diabetes. Methods: After a mean follow-up of 8.4 years (11.7 years in Oklahoma), 2877 (71.6 %) survivors were resubmitted to standardised direct ophthalmoscopy as at baseline. The presence of any retinopathy and PDR were recorded at each centre and their incidence estimated in those without retinopathy and PDR at baseline. The independent associations of these incidences with baseline risk factors are expressed as odds ratios derived from multiple logistic regression analyses, within individual centres (which included fasting plasma glucose in 8 and triglyceride in 5) and in pooled data. Results: Of the 4662 original patients, 465 (10.4 %) of those without and 77 (43.0 %) of those with baseline PDR had died (p < 0.001). Any retinopathy was newly reported at follow-up in 47.7 % and PDR in 9.7 % of those free of them at baseline, with reported incidences varying substantially among centres. Incident retinopathy appeared earlier in the known course of diabetes but incidence rates rose more slowly with duration in patients with Type II (non-insulin-dependent) diabetes mellitus than in those with Type I (insulin-dependent) diabetes mellitus. In pooled data and in some individual centres, any retinopathy incidence gave significantly positive odds ratios with age, diabetes duration, systolic pressure, plasma cholesterol, BMI, insulin treatment and proteinuria, and with fasting plasma glucose in the centres where it was measured. Positive odds ratios for PDR were similarly obtained for age, duration, insulin treatment, cholesterol, proteinuria and fasting glycaemia. Smoking status odds ratios were negative for both outcomes. Conclusion/interpretation: Incidence of ophthalmoscopically ascertained any retinopathy varied about twofold and of PDR about threefold among centres. Although, in part attributable to differences between observers, variation in incidence in all centres and in some cases within centres was associated with a number of baseline risk factors. Such associations are not likely due to observer variation or selection biases and emerged despite the imprecision of clinical ophthalmoscopy. Improved detection and control of these risk factors should reduce the impact of diabetic retinopathy and its consequences. [Diabetologia (2001) 44 [Suppl 2]: S 22–S 30] More... »

PAGES

s22

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/pl00002935

DOI

http://dx.doi.org/10.1007/pl00002935

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015126187

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11587046


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Angiopathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Retinopathy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "International Cooperation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Logistic Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ophthalmoscopy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Smoking", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "World Health Organization", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Unit for Metabolic Medicine, Guy's Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Unit for Metabolic Medicine, Guy's Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keen", 
        "givenName": "H.", 
        "id": "sg:person.01042343611.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "E. T.", 
        "id": "sg:person.015547137254.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015547137254.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Russell", 
        "givenName": "D.", 
        "id": "sg:person.01303234076.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303234076.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "3\u20134-2, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "3\u20134-2, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miki", 
        "givenName": "E.", 
        "id": "sg:person.014765754510.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014765754510.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA", 
          "id": "http://www.grid.ac/institutes/grid.419635.c", 
          "name": [
            "NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bennett", 
        "givenName": "P. H.", 
        "id": "sg:person.011034664412.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011034664412.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "M.", 
        "id": "sg:person.01012305351.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012305351.06"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "and the WHO Multinational Study Group", 
        "id": "sg:person.013726262617.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013726262617.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00405109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022665155", 
          "https://doi.org/10.1007/bf00405109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/pl00002934", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048891551", 
          "https://doi.org/10.1007/pl00002934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/pl00002936", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012369862", 
          "https://doi.org/10.1007/pl00002936"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-09", 
    "datePublishedReg": "2001-09-01", 
    "description": "Abstract.Aims/hypothesis: We aimed to estimate incidences of any retinopathy and proliferative diabetic retinopathy (PDR) by direct ophthalmoscopy and relate them to baseline risk factors in re-examined diabetic survivors from 10 centres of the WHO Multinational Study of Vascular Disease in Diabetes. Methods: After a mean follow-up of 8.4 years (11.7 years in Oklahoma), 2877 (71.6 %) survivors were resubmitted to standardised direct ophthalmoscopy as at baseline. The presence of any retinopathy and PDR were recorded at each centre and their incidence estimated in those without retinopathy and PDR at baseline. The independent associations of these incidences with baseline risk factors are expressed as odds ratios derived from multiple logistic regression analyses, within individual centres (which included fasting plasma glucose in 8 and triglyceride in 5) and in pooled data. Results: Of the 4662 original patients, 465 (10.4 %) of those without and 77 (43.0 %) of those with baseline PDR had died (p < 0.001). Any retinopathy was newly reported at follow-up in 47.7 % and PDR in 9.7 % of those free of them at baseline, with reported incidences varying substantially among centres. Incident retinopathy appeared earlier in the known course of diabetes but incidence rates rose more slowly with duration in patients with Type II (non-insulin-dependent) diabetes mellitus than in those with Type I (insulin-dependent) diabetes mellitus. In pooled data and in some individual centres, any retinopathy incidence gave significantly positive odds ratios with age, diabetes duration, systolic pressure, plasma cholesterol, BMI, insulin treatment and proteinuria, and with fasting plasma glucose in the centres where it was measured. Positive odds ratios for PDR were similarly obtained for age, duration, insulin treatment, cholesterol, proteinuria and fasting glycaemia. Smoking status odds ratios were negative for both outcomes. Conclusion/interpretation: Incidence of ophthalmoscopically ascertained any retinopathy varied about twofold and of PDR about threefold among centres. Although, in part attributable to differences between observers, variation in incidence in all centres and in some cases within centres was associated with a number of baseline risk factors. Such associations are not likely due to observer variation or selection biases and emerged despite the imprecision of clinical ophthalmoscopy. Improved detection and control of these risk factors should reduce the impact of diabetic retinopathy and its consequences. [Diabetologia (2001) 44 [Suppl 2]: S 22\u2013S 30]", 
    "genre": "article", 
    "id": "sg:pub.10.1007/pl00002935", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2716795", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "keywords": [
      "proliferative diabetic retinopathy", 
      "WHO Multinational Study", 
      "baseline risk factors", 
      "risk factors", 
      "odds ratio", 
      "positive odds ratio", 
      "vascular disease", 
      "diabetic retinopathy", 
      "insulin treatment", 
      "multinational study", 
      "multiple logistic regression analysis", 
      "appearance of retinopathy", 
      "course of diabetes", 
      "individual centers", 
      "logistic regression analysis", 
      "diabetic survivors", 
      "incident retinopathy", 
      "retinopathy incidence", 
      "diabetes duration", 
      "systolic pressure", 
      "proliferative retinopathy", 
      "plasma glucose", 
      "independent association", 
      "incidence rate", 
      "plasma cholesterol", 
      "original patients", 
      "reported incidences", 
      "retinopathy", 
      "incidence", 
      "diabetes", 
      "pooled data", 
      "baseline", 
      "mellitus", 
      "proteinuria", 
      "patients", 
      "regression analysis", 
      "such associations", 
      "disease", 
      "type I", 
      "survivors", 
      "cholesterol", 
      "duration", 
      "type II", 
      "age", 
      "treatment", 
      "association", 
      "selection biases", 
      "BMI", 
      "glycaemia", 
      "factors", 
      "center", 
      "progression", 
      "outcomes", 
      "study", 
      "glucose", 
      "years", 
      "course", 
      "ratio", 
      "data", 
      "differences", 
      "control", 
      "cases", 
      "appearance", 
      "rate", 
      "presence", 
      "pressure", 
      "twofold", 
      "consequences", 
      "detection", 
      "number", 
      "imprecision", 
      "impact", 
      "analysis", 
      "part", 
      "variation", 
      "observer", 
      "biases"
    ], 
    "name": "The appearance of retinopathy and progression to proliferative retinopathy: the WHO multinational study of vascular disease in diabetes", 
    "pagination": "s22", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015126187"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/pl00002935"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11587046"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/pl00002935", 
      "https://app.dimensions.ai/details/publication/pub.1015126187"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_332.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/pl00002935"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/pl00002935'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/pl00002935'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/pl00002935'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/pl00002935'


 

This table displays all metadata directly associated to this object as RDF triples.

257 TRIPLES      21 PREDICATES      120 URIs      109 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/pl00002935 schema:about N140c639fdb494faf9aabe43701cb0e1b
2 N45163db65fd242b084bcd27da36a29e0
3 N50dd75f3a30a4982a0c6dab1b28d69be
4 N5bfcefa9dd014b46969d8bd9ced6cdf8
5 N7c6675ac1b26425aa237aa27a50847d4
6 N8d1eb19215b8451a8fa1a2e21717b042
7 N94212a943fb3439e993d59ffdc640b31
8 Na105b9cd55ee4810a6ac652def3174a9
9 Na4f03eecb1aa453796c1e81f64f92590
10 Nb8b56e289c724351b76a2bacd1f41f22
11 Nbeb1ada2045a4c2da9905f50192ffd3f
12 Nc5ce3072287344b7b6fe1edb895328e3
13 Ndf4d75f20b2047c1a33b7cb57785744c
14 Neb8ec1890954456a9d902d285862db30
15 anzsrc-for:11
16 anzsrc-for:1117
17 schema:author Nbad3998daf3e47168d8c870915123b2c
18 schema:citation sg:pub.10.1007/bf00405109
19 sg:pub.10.1007/pl00002934
20 sg:pub.10.1007/pl00002936
21 schema:datePublished 2001-09
22 schema:datePublishedReg 2001-09-01
23 schema:description Abstract.Aims/hypothesis: We aimed to estimate incidences of any retinopathy and proliferative diabetic retinopathy (PDR) by direct ophthalmoscopy and relate them to baseline risk factors in re-examined diabetic survivors from 10 centres of the WHO Multinational Study of Vascular Disease in Diabetes. Methods: After a mean follow-up of 8.4 years (11.7 years in Oklahoma), 2877 (71.6 %) survivors were resubmitted to standardised direct ophthalmoscopy as at baseline. The presence of any retinopathy and PDR were recorded at each centre and their incidence estimated in those without retinopathy and PDR at baseline. The independent associations of these incidences with baseline risk factors are expressed as odds ratios derived from multiple logistic regression analyses, within individual centres (which included fasting plasma glucose in 8 and triglyceride in 5) and in pooled data. Results: Of the 4662 original patients, 465 (10.4 %) of those without and 77 (43.0 %) of those with baseline PDR had died (p < 0.001). Any retinopathy was newly reported at follow-up in 47.7 % and PDR in 9.7 % of those free of them at baseline, with reported incidences varying substantially among centres. Incident retinopathy appeared earlier in the known course of diabetes but incidence rates rose more slowly with duration in patients with Type II (non-insulin-dependent) diabetes mellitus than in those with Type I (insulin-dependent) diabetes mellitus. In pooled data and in some individual centres, any retinopathy incidence gave significantly positive odds ratios with age, diabetes duration, systolic pressure, plasma cholesterol, BMI, insulin treatment and proteinuria, and with fasting plasma glucose in the centres where it was measured. Positive odds ratios for PDR were similarly obtained for age, duration, insulin treatment, cholesterol, proteinuria and fasting glycaemia. Smoking status odds ratios were negative for both outcomes. Conclusion/interpretation: Incidence of ophthalmoscopically ascertained any retinopathy varied about twofold and of PDR about threefold among centres. Although, in part attributable to differences between observers, variation in incidence in all centres and in some cases within centres was associated with a number of baseline risk factors. Such associations are not likely due to observer variation or selection biases and emerged despite the imprecision of clinical ophthalmoscopy. Improved detection and control of these risk factors should reduce the impact of diabetic retinopathy and its consequences. [Diabetologia (2001) 44 [Suppl 2]: S 22–S 30]
24 schema:genre article
25 schema:isAccessibleForFree true
26 schema:isPartOf N7acf614e98e347ecbd2e57ba0ef2267d
27 Nb982d7d5009147ec925670575317ee2e
28 sg:journal.1001482
29 schema:keywords BMI
30 WHO Multinational Study
31 age
32 analysis
33 appearance
34 appearance of retinopathy
35 association
36 baseline
37 baseline risk factors
38 biases
39 cases
40 center
41 cholesterol
42 consequences
43 control
44 course
45 course of diabetes
46 data
47 detection
48 diabetes
49 diabetes duration
50 diabetic retinopathy
51 diabetic survivors
52 differences
53 disease
54 duration
55 factors
56 glucose
57 glycaemia
58 impact
59 imprecision
60 incidence
61 incidence rate
62 incident retinopathy
63 independent association
64 individual centers
65 insulin treatment
66 logistic regression analysis
67 mellitus
68 multinational study
69 multiple logistic regression analysis
70 number
71 observer
72 odds ratio
73 original patients
74 outcomes
75 part
76 patients
77 plasma cholesterol
78 plasma glucose
79 pooled data
80 positive odds ratio
81 presence
82 pressure
83 progression
84 proliferative diabetic retinopathy
85 proliferative retinopathy
86 proteinuria
87 rate
88 ratio
89 regression analysis
90 reported incidences
91 retinopathy
92 retinopathy incidence
93 risk factors
94 selection biases
95 study
96 such associations
97 survivors
98 systolic pressure
99 treatment
100 twofold
101 type I
102 type II
103 variation
104 vascular disease
105 years
106 schema:name The appearance of retinopathy and progression to proliferative retinopathy: the WHO multinational study of vascular disease in diabetes
107 schema:pagination s22
108 schema:productId N1aea5fd9fc2a4b4d829afd8e66a9143f
109 Na5456f37883f41d2b7313edc069aced1
110 Ne4b5ed88460640408f5c4718e369085f
111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015126187
112 https://doi.org/10.1007/pl00002935
113 schema:sdDatePublished 2022-12-01T06:22
114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
115 schema:sdPublisher Nf9d1b607172a4b81b4a2ec4d276439d2
116 schema:url https://doi.org/10.1007/pl00002935
117 sgo:license sg:explorer/license/
118 sgo:sdDataset articles
119 rdf:type schema:ScholarlyArticle
120 N140c639fdb494faf9aabe43701cb0e1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Odds Ratio
122 rdf:type schema:DefinedTerm
123 N15998d7c4b4e49a1a1aa027383951978 rdf:first sg:person.013726262617.64
124 rdf:rest rdf:nil
125 N1aea5fd9fc2a4b4d829afd8e66a9143f schema:name dimensions_id
126 schema:value pub.1015126187
127 rdf:type schema:PropertyValue
128 N4259b1983f584755b58c3a17a5239c4d rdf:first sg:person.014765754510.49
129 rdf:rest Nbde32b9c57c74f0d8d2468b1ba9bdfc2
130 N45163db65fd242b084bcd27da36a29e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name International Cooperation
132 rdf:type schema:DefinedTerm
133 N50dd75f3a30a4982a0c6dab1b28d69be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Smoking
135 rdf:type schema:DefinedTerm
136 N5bfcefa9dd014b46969d8bd9ced6cdf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Diabetes Mellitus, Type 1
138 rdf:type schema:DefinedTerm
139 N7acf614e98e347ecbd2e57ba0ef2267d schema:issueNumber Suppl 2
140 rdf:type schema:PublicationIssue
141 N7c6675ac1b26425aa237aa27a50847d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Diabetes Mellitus, Type 2
143 rdf:type schema:DefinedTerm
144 N8d1eb19215b8451a8fa1a2e21717b042 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Logistic Models
146 rdf:type schema:DefinedTerm
147 N94212a943fb3439e993d59ffdc640b31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Female
149 rdf:type schema:DefinedTerm
150 Na0e8418b7c124cecb8871b8cf7fd86b8 rdf:first sg:person.015547137254.79
151 rdf:rest Ne54193744b2c4b5b9ca9a8637b1f9675
152 Na105b9cd55ee4810a6ac652def3174a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name World Health Organization
154 rdf:type schema:DefinedTerm
155 Na4f03eecb1aa453796c1e81f64f92590 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Male
157 rdf:type schema:DefinedTerm
158 Na5456f37883f41d2b7313edc069aced1 schema:name doi
159 schema:value 10.1007/pl00002935
160 rdf:type schema:PropertyValue
161 Naae46dae48c944a6a073f0842937719b rdf:first sg:person.01012305351.06
162 rdf:rest N15998d7c4b4e49a1a1aa027383951978
163 Nb8b56e289c724351b76a2bacd1f41f22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Age Factors
165 rdf:type schema:DefinedTerm
166 Nb982d7d5009147ec925670575317ee2e schema:volumeNumber 44
167 rdf:type schema:PublicationVolume
168 Nbad3998daf3e47168d8c870915123b2c rdf:first sg:person.01042343611.09
169 rdf:rest Na0e8418b7c124cecb8871b8cf7fd86b8
170 Nbde32b9c57c74f0d8d2468b1ba9bdfc2 rdf:first sg:person.011034664412.40
171 rdf:rest Naae46dae48c944a6a073f0842937719b
172 Nbeb1ada2045a4c2da9905f50192ffd3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Humans
174 rdf:type schema:DefinedTerm
175 Nc5ce3072287344b7b6fe1edb895328e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Diabetic Angiopathies
177 rdf:type schema:DefinedTerm
178 Ndf4d75f20b2047c1a33b7cb57785744c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Ophthalmoscopy
180 rdf:type schema:DefinedTerm
181 Ne4b5ed88460640408f5c4718e369085f schema:name pubmed_id
182 schema:value 11587046
183 rdf:type schema:PropertyValue
184 Ne54193744b2c4b5b9ca9a8637b1f9675 rdf:first sg:person.01303234076.61
185 rdf:rest N4259b1983f584755b58c3a17a5239c4d
186 Neb8ec1890954456a9d902d285862db30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Diabetic Retinopathy
188 rdf:type schema:DefinedTerm
189 Nf9d1b607172a4b81b4a2ec4d276439d2 schema:name Springer Nature - SN SciGraph project
190 rdf:type schema:Organization
191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical and Health Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
195 schema:name Public Health and Health Services
196 rdf:type schema:DefinedTerm
197 sg:grant.2716795 http://pending.schema.org/fundedItem sg:pub.10.1007/pl00002935
198 rdf:type schema:MonetaryGrant
199 sg:journal.1001482 schema:issn 0012-186X
200 1432-0428
201 schema:name Diabetologia
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01012305351.06 schema:affiliation grid-institutes:grid.266902.9
205 schema:familyName Lu
206 schema:givenName M.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012305351.06
208 rdf:type schema:Person
209 sg:person.01042343611.09 schema:affiliation grid-institutes:grid.239826.4
210 schema:familyName Keen
211 schema:givenName H.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09
213 rdf:type schema:Person
214 sg:person.011034664412.40 schema:affiliation grid-institutes:grid.419635.c
215 schema:familyName Bennett
216 schema:givenName P. H.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011034664412.40
218 rdf:type schema:Person
219 sg:person.01303234076.61 schema:affiliation grid-institutes:grid.266902.9
220 schema:familyName Russell
221 schema:givenName D.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303234076.61
223 rdf:type schema:Person
224 sg:person.013726262617.64 schema:familyName and the WHO Multinational Study Group
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013726262617.64
226 rdf:type schema:Person
227 sg:person.014765754510.49 schema:affiliation grid-institutes:None
228 schema:familyName Miki
229 schema:givenName E.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014765754510.49
231 rdf:type schema:Person
232 sg:person.015547137254.79 schema:affiliation grid-institutes:grid.266902.9
233 schema:familyName Lee
234 schema:givenName E. T.
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015547137254.79
236 rdf:type schema:Person
237 sg:pub.10.1007/bf00405109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022665155
238 https://doi.org/10.1007/bf00405109
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/pl00002934 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048891551
241 https://doi.org/10.1007/pl00002934
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/pl00002936 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012369862
244 https://doi.org/10.1007/pl00002936
245 rdf:type schema:CreativeWork
246 grid-institutes:None schema:alternateName 3–4-2, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan
247 schema:name 3–4-2, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan
248 rdf:type schema:Organization
249 grid-institutes:grid.239826.4 schema:alternateName Unit for Metabolic Medicine, Guy's Hospital, London, UK
250 schema:name Unit for Metabolic Medicine, Guy's Hospital, London, UK
251 rdf:type schema:Organization
252 grid-institutes:grid.266902.9 schema:alternateName Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA
253 schema:name Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA
254 rdf:type schema:Organization
255 grid-institutes:grid.419635.c schema:alternateName NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA
256 schema:name NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA
257 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...